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Also, external factors help to determine and predict what the organization 
expects in the event of the successful achievement of its goals and, conversely, 
in the event of failure. The main components of the analysis are: competitors, 
suppliers, customers and so on. There are a sufficient number of methods for 
strategic analysis of the external environment, consider some of them [1]: 
SWOT analysis, designed to obtain an assessment of the strength of the enter-
prise in the market, to assess the strengths and weaknesses of the organization; 
PEST analysis is an analysis that examines the political, economic, social and 
technological external factors that in the future affect the organization’s strategy 
and subsequent action plan; The profile of the environment and the method of 
weighing each factor is designed to compile a profile of the external, internal 
environment of the enterprise and its immediate environment; The model of the 
five forces of competition (according to M. Porter) is used to analyze competitors. 
Conclusion. Analysis of the external environment of the organization is 
very important for building an organization’s strategy and a very complex pro-
cess that requires constant attention to changes in the situation, assessing factors 
and establishing a connection between factors and those strengths and weak-
nesses of the organization, as well as opportunities and threats that exist in the 
external environment. This fact is undeniable that, without knowing the external 
environment, the organization will not be able to exist. The organization studies 
the environment in order to ensure the successful achievement of its goals, de-
velops a strategy for interacting with environmental factors that provides it with 
the most comfortable, stable and resilient coexistence. 
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Резюме – В данной статье рассмотрены проблемы фармацевтиче-
ской отрасли, а также отражены идеи по ее улучшению, проведено срав-
нение белорусской фармацевтической отрасли с мировой. В настоящее 
время очень большое внимание уделяется фармацевтической отрасли. 
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Эта тема особенно актуальна во время пандемии, которая сейчас стре-
мительно развивается. 
Resume – This article discusses the problems of the pharmaceutical indus-
try, as well as reflects ideas for its improvement, and compares the Belarusian 
pharmaceutical industry with the world. Currently, a lot of attention is paid to 
the pharmaceutical industry. This topic is particularly relevant during the pan-
demic, which is now rapidly developing. 
Introduction. Pharmaceutical industry is one of the most complex branch-
es of the chemical industry, characterized by a large number of sub-sectors, a 
high level of R&D and huge capital expenditures. The products of the modern 
pharmaceutical industry are becoming increasingly important for protecting the 
health of an ever-increasing global population. 
Main part. Pharmacology is the science of the interaction of chemicals 
with living biological systems, it comprehensively examines a medicine used for 
the treatment and prevention of various diseases and pathological conditions, as 
well as the mechanism of drug influence on organism. 
Every year, more and more modern pharmaceutical manufacturing plants 
are being opened, and more and more successful work is being done on the de-
velopment, introduction into production and launch of high-quality medicines. 
Currently, pharmacology plays a major role in building the economy. The 
pharmaceutical industry is currently one of the most important sectors of the 
world economy, which has a serious impact on the situation in neighboring are-
as: healthcare, insurance business, Finance, etc. At the same time, the increasing 
knowledge intensity of pharmaceutical production ensures the close develop-
ment of intersectoral relations with many industries, such as petrochemistry, bio-
technology and the military-industrial complex. 
The fact that Belarus has developed a unique drug for the treatment of brain 
tumors, which increases the life expectancy after surgery by 1.5 times compared 
to foreign analogues, also shows that the Belarusian drug is 50 times cheaper 
than foreign analogues. In the country, a drug for stomach cancer, the only drug 
in the world that is at the finish stage, is at the stage of completion of the study. 
Anti-cancer hydrogels are being actively created. The drug is in production in 
the form of biosalphets that dissolve themselves, and is used for the removal of 
tumors in the head and neck. A drug for the treatment of blood cancer in chil-
dren has been developed and widely used [1]. 
The work of all pharmaceutical companies in Belarus is aimed at providing 
the country's population with safe, effective and high-quality medicines. In the 
Republic of Belarus, there are enterprises and laboratories that own a number of 
unique productions, such as those that produce insulin, endocrine and biotechno-
logical products, psychotropic drugs, drugs for the treatment of cancer, tubercu-
losis, and many others. The Ministry of health of the Republic of Belarus is car-
rying out large-scale work on the modernization and technical re-equipment of 
pharmaceutical production, training of qualified specialists, development of new 
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import-substituting medicines, and increasing the production of domestic medi-
cines. Only medicines that have been passed state registration can be manufac-
tured and sold in the Republic of Belarus. To do this, the country has adopted 
and legislated quality standards for the production of medicines, allowing them 
to be sold only after passing quality control [2]. In fact, the Republic's drug mar-
ket is integrated into the world market. Belarus exports its pharmaceutical prod-
ucts to the international market and actively cooperates with other countries in 
order to achieve the following goals: joint production of medicines; increase in 
export; implementation of projects in the field of pharmacological genetics; con-
struction of joint modern pharmaceutical enterprises; expansion of cooperation 
in the field of health and medical science, pharmacology; establishment of 
pharmaceutical plants on the territory of other countries; presentation of the po-
tential of  Belarusian pharmaceutical industry and much more. However, there 
are also problems: 
– to successfully sell medicines abroad, Belarusian pharmaceutical compa-
nies lack a competent marketing policy that would promote Belarusian products 
on the foreign market. Unfortunately, Belarusian medicinal products are not al-
ways presented in modern design packaging; 
– by all indicators, Belarusian drugs are identical to foreign analogues, but 
they are cheaper than imported ones. However, many doctors and patients have 
less confidence in domestic medicines than in imported ones. I believe that this 
is due to the fact that currently there is a generation of doctors whose profes-
sional experience was formed at a time when the range of Belarusian medicines 
was not presented at all. There is also a problem in the shortage of narrow-
profile specialists in small and medium-sized cities-doctors who, in turn, would 
study the entire range of medicines in depth and could correctly and universally 
prescribe Belarusian medicines, but instead, broad-profile specialists do not go 
into the study of the spectrum of action of Belarusian medicines and prescribe 
imported medicines, assuming that they are more effective; 
– a huge share in the final price of a drug is taken by operations for pur-
chasing raw materials and selling finished products through intermediaries. 
Sometimes the share of intermediaries in the total cost of a medicine reaches up 
to 50 %, which makes this medicine unreasonably expensive. The solution to 
this problem is especially relevant today, when the world is in a fierce struggle 
for sales markets and price competition; 
– access to foreign markets of licensed drugs. For example, the license for a 
unique drug developed in Belarus for the treatment of brain tumors was sold to 
Switzerland due to lack of funds for a complex of expensive tests for registering 
the drug abroad; 
– a serious danger is the penetration of counterfeit medicines into the Bela-
rusian market, which can damage people's health, so only domestic pharmacolo-
gy can protect against such threats. 
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Ideas to improve the situation: 
– active attraction of foreign direct investment in the creation of new origi-
nal domestic medicines; 
– increasing the export potential of pharmaceuticals; 
– to develop in new directions of pharmacology, for example in pharmaco-
genetics; 
– increase production and dynamic development of innovative products; 
– increase the competitiveness and investment attractiveness of  
pharmacology. 
Conclusion. Belarus has shown good progress in the development of the 
pharmaceutical industry in recent years, ensuring an increasing presence of do-
mestic medicines on the market every year, and boldly entering the foreign mar-
ket. It is necessary to further increase the percentage of Belarusian and imported 
medicines in the direction of Belarusian ones, making them accessible to all cat-
egories of the population and effective in terms of medicinal properties. 
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Резюме – Статья рассматривает ключи к успеху молочной промыш-
ленности в Беларуси. В ней дан краткий обзор усовершенствований ас-
сортимента, положительных сдвигов в законодательной сфере, регули-
рующей отрасль и в целом о ее либерализации, что вносит свой вклад в 
общую картину успеха. 
Resume – The article considers the keys to success in the arena of the dairy 
industry in the Republic of Belarus. It outlines great improvements in the sphere, 
the main trends regarding range of products, liberalization of the industry and 
etc.  Some changes in the regulatory framework are also mentioned, as they 
contribute a lot in its success. 
Introduction. The dairy industry is considered the basis of the agro-
industrial complex of the Republic of Belarus. Sustainable provision of abso-
